JDQ-443
Modify Date: 2024-01-02 01:20:46
JDQ-443 structure
|
Common Name | JDQ-443 | ||
|---|---|---|---|---|
| CAS Number | 2653994-08-0 | Molecular Weight | 526.03 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H28ClN7O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of JDQ-443JDQ-443 (example 1a) is a covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1)[1]. |
| Name | JDQ-443 |
|---|
| Description | JDQ-443 (example 1a) is a covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1)[1]. |
|---|---|
| Related Catalog | |
| Target |
KRas G12C |
| In Vitro | JDQ-443 (NVP-JDQ443) traps the GDP-bound inactive conformation of KRAS[1]. |
| References |
[1]. LIU BO, et al. PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS. Patent WO2021120890A1. |
| Molecular Formula | C29H28ClN7O |
|---|---|
| Molecular Weight | 526.03 |